Jenny Klintman
1 – 10 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
SAMHD1 Limits the Efficacy of Forodesine in Leukemia by Protecting Cells against the Cytotoxicity of dGTP
(
- Contribution to journal › Article
-
Mark
The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor development
(
- Contribution to journal › Article
- 2019
-
Mark
First line therapy in chronic lymphocytic leukemia : a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013
(
- Contribution to journal › Article
- 2018
-
Mark
Clinical-grade validation of whole genome sequencing reveals robust detection of low-frequency variants and copy number alterations in CLL
(
- Contribution to journal › Article
-
Mark
The Genomic Landscape of Chronic Lymphocytic Leukaemia: Clinical Implications
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2017
-
Mark
Indications of underdiagnosis of atypical haemolytic uraemic syndrome in a cohort referred to the Coagulation Unit in Malmo, Sweden, for analysis of ADAMTS13 2007–2012
(
- Contribution to journal › Article
-
Mark
Application of whole-exome sequencing to direct the specific functional testing and diagnosis of rare inherited bleeding disorders in patients from the Öresund Region, Scandinavia
(
- Contribution to journal › Article
-
Mark
At the Cross Section of Thrombotic Microangiopathy and Atypical Hemolytic Uremic Syndrome : A Narrative Review of Differential Diagnostics and a Problematization of Nomenclature
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Blodsjukdomar
2016) p.587-621(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Epidemiological aspects of inhibitor development in hemophilia and strategies of management
(
- Contribution to journal › Scientific review